Acute 0 5 0 5 B-chronic_disease
major 6 11 6 11 I-chronic_disease
illness 12 19 12 19 I-chronic_disease

Albumin 0 7 20 27 B-clinical_variable
< 8 9 28 29 O
3 10 11 30 31 B-upper_bound
g 12 13 32 33 I-upper_bound
/ 13 14 33 34 I-upper_bound
dl 14 16 34 36 I-upper_bound

Disease 0 7 37 44 O
measurable 8 18 45 55 O
or 19 21 56 58 O
evaluable 22 31 59 68 O
as 32 34 69 71 O
defined 35 42 72 79 O
by 43 45 80 82 O
RECIST 46 52 83 89 O
1.1 53 56 90 93 O
, 56 57 93 94 O
a 58 59 95 96 O
mass 60 64 97 101 B-clinical_variable
of 65 67 102 104 O
greater 68 75 105 112 O
than 76 80 113 117 O
1 81 82 118 119 B-lower_bound
cm 82 84 119 121 I-lower_bound
in 85 87 122 124 O
the 88 91 125 128 O
long 92 96 129 133 O
axis 97 101 134 138 O
and/or 102 108 139 145 O
other 109 114 146 151 O
tumor 115 120 152 157 B-cancer
response 121 129 158 166 O
criteria 130 138 167 175 O
from 139 143 176 180 O
an 144 146 181 183 O
MSKCC 147 152 184 189 O
IRB 153 156 190 193 O
- 156 157 193 194 O
approved 157 165 194 202 O
clinical 166 174 203 211 O
research 175 183 212 220 O
protocol 184 192 221 229 O

Hepatic 0 7 230 237 O
: 7 8 237 238 O
from 9 13 239 243 O
assays 14 20 244 250 O
obtained 21 29 251 259 O
within 30 36 260 266 O
3 37 38 267 268 B-lower_bound
- 38 39 268 269 O
4 39 40 269 270 B-upper_bound
weeks 41 46 271 276 I-upper_bound
prior 47 52 277 282 I-upper_bound
to 53 55 283 285 O
study 56 61 286 291 O
enrollment 62 72 292 302 O

Inability 0 9 303 312 O
or 10 12 313 315 O
refusal 13 20 316 323 O
to 21 23 324 326 O
have 24 28 327 331 O
at 29 31 332 334 O
least 32 37 335 340 O
one 38 41 341 344 B-lower_bound
peripheral 42 52 345 355 O
intravenous 53 64 356 367 O
line 65 69 368 372 O
for 70 73 373 376 O
intravenous 74 85 377 388 O
access 86 92 389 395 O
( 93 94 396 397 O
as 94 96 397 399 O
applicable 97 107 400 410 O
to 108 110 411 413 O
the 111 114 414 417 O
day 115 118 418 421 O
of 119 121 422 424 O
[ 122 123 425 426 O
1 123 124 426 427 O
- 124 125 427 428 O
13C 125 128 428 431 O
] 128 129 431 432 O
pyruvate 130 138 433 441 O
injection 139 148 442 451 O
) 148 149 451 452 O

Negative 0 8 453 461 B-pregnancy
serum 9 14 462 467 I-pregnancy
or 15 17 468 470 I-pregnancy
urine 18 23 471 476 I-pregnancy
pregnancy 24 33 477 486 I-pregnancy
test 34 38 487 491 O
for 39 42 492 495 O
female 43 49 496 502 B-gender
patients 50 58 503 511 I-gender
of 59 61 512 514 O
childbearing 62 74 515 527 O
age 75 78 528 531 B-age
and 79 82 532 535 O
potential 83 92 536 545 O
( 93 94 546 547 O
as 94 96 547 549 O
defined 97 104 550 557 O
by 105 107 558 560 O
MSKCC 108 113 561 566 O
Standards 114 123 567 576 O
& 124 125 577 578 O
Guidelines 126 136 579 589 O
) 136 137 589 590 O
, 137 138 590 591 O
from 139 143 592 596 O
assays 144 150 597 603 O
obtained 151 159 604 612 O
< 160 161 613 614 O
2 162 163 615 616 B-upper_bound
weeks 164 169 617 622 I-upper_bound
prior 170 175 623 628 I-upper_bound
to 176 178 629 631 O
study 179 184 632 637 O
enrollment 185 195 638 648 O

Patients 0 8 649 657 O
identified 9 19 658 668 O
by 20 22 669 671 O
a 23 24 672 673 O
radiologist 25 36 674 685 O
to 37 39 686 688 O
have 40 44 689 693 O
a 45 46 694 695 O
brain 47 52 696 701 B-chronic_disease
lesion 53 59 702 708 I-chronic_disease
with 60 64 709 713 O
high 65 69 714 718 O
suspicion 70 79 719 728 O
for 80 83 729 732 O
neoplasm 84 92 733 741 B-cancer
given 93 98 742 747 O
MRI 99 102 748 751 B-treatment
features 103 111 752 760 O

Patients 0 8 761 769 O
with 9 13 770 774 O
history 14 21 775 782 O
of 22 24 783 785 O
histologically 25 39 786 800 O
- 39 40 800 801 O
confirmed 40 49 801 810 O
malignant 50 59 811 820 B-cancer
solid 60 65 821 826 B-cancer
tumor 66 71 827 832 I-cancer
( 72 73 833 834 O
histology 73 82 834 843 O
confirmed 83 92 844 853 O
by 93 95 854 856 O
MSKCC 96 101 857 862 O
Department 102 112 863 873 O
of 113 115 874 876 O
Pathology 116 125 877 886 O
. 125 126 886 887 O
) 126 127 887 888 O

Refusal 0 7 889 896 O
or 8 10 897 899 O
inability 11 20 900 909 O
to 21 23 910 912 O
tolerate 24 32 913 921 O
the 33 36 922 925 O
scanning 37 45 926 934 O
procedure 46 55 935 944 O
( 56 57 945 946 O
e.g. 57 61 946 950 O
, 61 62 950 951 O
due 63 66 952 955 O
to 67 69 956 958 O
claustrophobia 70 84 959 973 B-chronic_disease
) 84 85 973 974 O

brain 0 5 975 980 B-cancer
or 6 8 981 983 O
metastatic 9 19 984 994 B-cancer
cancer 20 26 995 1001 I-cancer

pacemakers 0 10 1002 1012 B-treatment
and 11 14 1013 1016 O
metal 15 20 1017 1022 B-treatment
clips 21 26 1023 1028 I-treatment
located 27 34 1029 1036 O
in 35 37 1037 1039 O
the 38 41 1040 1043 O
patient 42 49 1044 1051 O

patients 0 8 1052 1060 O
with 9 13 1061 1065 O
brain 14 19 1066 1071 B-chronic_disease
lesions 20 27 1072 1079 I-chronic_disease

patients 0 8 1080 1088 O
with 9 13 1089 1093 O
sarcoma 14 21 1094 1101 B-cancer

unstable 0 8 1102 1110 O
cardiovascular 9 23 1111 1125 B-chronic_disease
condition 24 33 1126 1135 I-chronic_disease

